Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

References for PMC Articles for PubMed (Select 19920184)

1.

p21/Cip1 and p27/Kip1 Are essential molecular targets of inositol hexaphosphate for its antitumor efficacy against prostate cancer.

Roy S, Gu M, Ramasamy K, Singh RP, Agarwal C, Siriwardana S, Sclafani RA, Agarwal R.

Cancer Res. 2009 Feb 1;69(3):1166-73. doi: 10.1158/0008-5472.CAN-08-3115. Epub 2009 Jan 27.

2.

Glycogen synthase kinase-3 and cancer: good cop, bad cop?

Patel S, Woodgett J.

Cancer Cell. 2008 Nov 4;14(5):351-3. doi: 10.1016/j.ccr.2008.10.013.

3.

Small-molecule inhibitors of PDK1.

Peifer C, Alessi DR.

ChemMedChem. 2008 Dec;3(12):1810-38. doi: 10.1002/cmdc.200800195. Review.

PMID:
18972468
4.

Glycogen synthase kinase 3beta regulates cell death induced by synthetic triterpenoids.

Venè R, Larghero P, Arena G, Sporn MB, Albini A, Tosetti F.

Cancer Res. 2008 Sep 1;68(17):6987-96. doi: 10.1158/0008-5472.CAN-07-6362.

5.

Prostate cancer.

Damber JE, Aus G.

Lancet. 2008 May 17;371(9625):1710-21. doi: 10.1016/S0140-6736(08)60729-1. Review.

PMID:
18486743
6.

Chemopreventive efficacy of inositol hexaphosphate against prostate tumor growth and progression in TRAMP mice.

Raina K, Rajamanickam S, Singh RP, Agarwal R.

Clin Cancer Res. 2008 May 15;14(10):3177-84. doi: 10.1158/1078-0432.CCR-07-5275.

7.

Tumour maintenance is mediated by eNOS.

Lim KH, Ancrile BB, Kashatus DF, Counter CM.

Nature. 2008 Apr 3;452(7187):646-9. doi: 10.1038/nature06778. Epub 2008 Mar 16.

8.

The role of angiogenesis inhibitors in prostate cancer.

Aragon-Ching JB, Dahut WL.

Cancer J. 2008 Jan-Feb;14(1):20-5. doi: 10.1097/PPO.0b013e318161c014. Review.

PMID:
18303479
9.

The VHL tumor suppressor and HIF: insights from genetic studies in mice.

Kapitsinou PP, Haase VH.

Cell Death Differ. 2008 Apr;15(4):650-9. doi: 10.1038/sj.cdd.4402313. Epub 2008 Jan 25. Review.

10.

Interplay of nuclear factor-kappaB and B-myb in the negative regulation of androgen receptor expression by tumor necrosis factor alpha.

Ko S, Shi L, Kim S, Song CS, Chatterjee B.

Mol Endocrinol. 2008 Feb;22(2):273-86. Epub 2007 Nov 1.

11.

PECAM-1: a multi-functional molecule in inflammation and vascular biology.

Woodfin A, Voisin MB, Nourshargh S.

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2514-23. Epub 2007 Sep 13. Review.

12.

Dynamic FoxO transcription factors.

Huang H, Tindall DJ.

J Cell Sci. 2007 Aug 1;120(Pt 15):2479-87. Review.

13.

AKT/PKB signaling: navigating downstream.

Manning BD, Cantley LC.

Cell. 2007 Jun 29;129(7):1261-74. Review.

14.

Silibinin inhibits inflammatory and angiogenic attributes in photocarcinogenesis in SKH-1 hairless mice.

Gu M, Singh RP, Dhanalakshmi S, Agarwal C, Agarwal R.

Cancer Res. 2007 Apr 1;67(7):3483-91.

15.

Protection against cancer by dietary IP6 and inositol.

Vucenik I, Shamsuddin AM.

Nutr Cancer. 2006;55(2):109-25. Review.

PMID:
17044765
16.

Phytic acid: a phytochemical with complementary and alternative benefits.

Bakewell S.

Cancer Biol Ther. 2006 Sep;5(9):1134-5. Epub 2006 Sep 7. No abstract available.

17.

The role of nitric oxide in tumour progression.

Fukumura D, Kashiwagi S, Jain RK.

Nat Rev Cancer. 2006 Jul;6(7):521-34. Review.

PMID:
16794635
18.

Reactive oxygen species regulate insulin-induced VEGF and HIF-1alpha expression through the activation of p70S6K1 in human prostate cancer cells.

Zhou Q, Liu LZ, Fu B, Hu X, Shi X, Fang J, Jiang BH.

Carcinogenesis. 2007 Jan;28(1):28-37. Epub 2006 Jun 13.

19.

An androgen-independent androgen receptor function protects from inositol hexakisphosphate toxicity in the PC3/PC3(AR) prostate cancer cell lines.

Diallo JS, Péant B, Lessard L, Delvoye N, Le Page C, Mes-Masson AM, Saad F.

Prostate. 2006 Sep 1;66(12):1245-56.

PMID:
16705740
20.

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer.

Mulholland DJ, Dedhar S, Wu H, Nelson CC.

Oncogene. 2006 Jan 19;25(3):329-37. Review.

PMID:
16421604
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk